2023 International Congress Archives - Page 89 of 186

Identification of reproducible metabolites for Parkinson’s Disease diagnosis using clinical data and computational modelling

X. Luo, YJ. Liu, A. Balck, C. Klein, R. Fleming (Galway, Ireland)
Identification of xylopropamine as a potential dopamine D2 receptor agonist through computational drug discovery pipeline

B. Ugbedeojo, P. Adoyi, A. Abah, O. Onimisi, S. Musa, A. Omoniyi (Zaria, Nigeria)
Identification of ZYIL1, a novel NLR family pyrin domain containing 3 protein inhibitor: a potential disease modifier in Parkinson’s disorder

A. Chatterjee (Ahmedabad, India)
Identifying a path to improve diagnostic delay and access to care for PSP, CBS, and MSA

M. Bruno, F. Ali, M. Dale, M. Schmidt, M. Comeau, C. Spears, J. Shurer (Honolulu, USA)
Identifying delirium in Parkinson’s: evaluation of existing tools and measures

R. Lawson, S. Richardson, F. Gerakios, G. Bate (Newcastle upon Tyne, United Kingdom)
Identifying neural biomarkers of motivated behavior in Parkinson’s disease using sensing-capable DBS devices

N. Provenza, S. Rajesh, N. Diab, S. Reddy, B. Lamichhane, A. Sabharwal, J. Herron, Y. Gazes, C. Le Heron, S. Sheth, N. Vanegas-Arroyave (Houston, USA)
Identifying prodromal NMS in a population-based recruitment strategy: Kassel data of Healthy Brain Ageing

S. Schade, C. Vega Moreno, C. Horlings, A. Garrido, T. Marques, P. Mahlknecht, E. Bryan, C. Gomes, C. Pauly, S. Ghosh, K. Rege, R. Rawal, T. Wicke, E. Lang, S. Schnell, V. Satagopam, K. Seppi, M. Marti, E. Tolosa, W. Poewe, R. Krüger, C. Trenkwalder, B. Mollenhauer (Kassel, Germany)
Idiopathic Intracranial Hypertension as the presenting symptom in Wilson’s Disease: how is it possible?

V. Mesquita, F. Rolim, A. Gomes, R. Carvalho, P. Matos, A. Marinho, N. Frota, F. Carvalho (Fortaleza, Brazil)
Image-guided programing in useful in DBS for Parkinson’s disease

S. Marmol, J. Moll, H. Bullock, I. Haq, J. Jagid, C. Luca (Miami, USA)
Imaging the noradrenergic system in Parkinson’s disease: A [11C]Yohimbine PET and neuromelanin MRI study

C. Laurencin, S. Lancelot, M. Huddlestone, S. Brosse, I. Merida, N. Costes, J. Redouté, S. Thobois, P. Boulinguez, B. Ballanger (Lyon, France)